STOCK TITAN

Compass: D1 Capital reports 6.1% beneficial stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Compass, Inc. (COMP) is the subject of a Schedule 13G in which D1 Capital Partners L.P., an investment manager, and Daniel Sundheim, who indirectly controls it, each may be deemed to beneficially own 45,896,143 Class A common shares, or 6.1% of the class, as of September 30, 2026. Both reported shared voting and dispositive power over the shares. The investment vehicle and/or its subsidiary has the right to receive dividends and sale proceeds; the statement says the filing is not an admission that either reporting person is a beneficial owner for Exchange Act purposes.

Beneficially owned Class A shares 45,896,143 shares Reported by each of D1 Capital Partners L.P. and Daniel Sundheim as of September 30, 2026.
Percent of class 6.1% Reported beneficial ownership of Compass Class A common stock.
Class A shares outstanding 757,522,197 shares As of August 3, 2026; used to calculate the reported ownership percentage.
beneficially own regulatory
"may be deemed to beneficially own the shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Shared Voting Power regulatory
"Shared Voting Power 45,896,143"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 45,896,143"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many COMP shares did D1 Capital Partners and Daniel Sundheim report?

They each reported that they may be deemed to beneficially own 45,896,143 Class A shares, or 6.1% of the class, as of September 30, 2026. Both reported shared voting and dispositive power over the shares.

Who receives dividends from the COMP shares reported by D1 Capital Partners?

D1 Capital Partners Master LP, the investment vehicle, and/or its subsidiary has the right to receive and direct the receipt of dividends and proceeds from the sale of the reported shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





20464U100

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



D1 Capital Partners L.P.
Signature:/s/ Amanda Hector
Name/Title:Amanda Hector, General Counsel and Chief Compliance Officer
Date:11/16/2026
Daniel Sundheim
Signature:/s/ Daniel Sundheim
Name/Title:Daniel Sundheim, Individually
Date:11/16/2026
Exhibit Information

Exhibit 99.1: Joint Filing Agreement

Keep reading